Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.46 - $42.69 $4 - $426
-10 Reduced 0.04%
23,628 $11,000
Q3 2022

Nov 02, 2022

SELL
$0.63 - $33.0 $3,148 - $164,934
-4,998 Reduced 17.45%
23,638 $15,000
Q2 2022

Aug 01, 2022

SELL
$0.63 - $0.96 $71 - $108
-113 Reduced 0.39%
28,636 $23,000
Q1 2022

May 04, 2022

SELL
$0.5 - $1.06 $410 - $869
-820 Reduced 2.77%
28,749 $20,000
Q4 2021

Feb 07, 2022

SELL
$0.92 - $1.22 $652 - $864
-709 Reduced 2.34%
29,569 $30,000
Q3 2021

Nov 02, 2021

SELL
$0.67 - $1.51 $596,540 - $1.34 Million
-890,359 Reduced 96.71%
30,278 $39,000
Q2 2021

Aug 03, 2021

SELL
$0.75 - $1.1 $42,990 - $63,053
-57,321 Reduced 5.86%
920,637 $713,000
Q1 2021

May 04, 2021

SELL
$0.96 - $1.74 $40,777 - $73,909
-42,477 Reduced 4.16%
977,958 $1.03 Million
Q4 2020

Feb 01, 2021

SELL
$0.76 - $1.47 $123,707 - $239,276
-162,773 Reduced 13.76%
1,020,435 $1.39 Million
Q3 2020

Nov 09, 2020

SELL
$0.67 - $0.96 $24,873 - $35,639
-37,124 Reduced 3.04%
1,183,208 $907,000
Q2 2020

Aug 07, 2020

SELL
$0.52 - $0.92 $1.39 Million - $2.46 Million
-2,672,895 Reduced 68.66%
1,220,332 $943,000
Q1 2020

May 04, 2020

BUY
$0.6 - $2.31 $1.51 Million - $5.83 Million
2,524,597 Added 184.46%
3,893,227 $2.34 Million
Q4 2019

Feb 06, 2020

SELL
$0.63 - $2.27 $1.66 Million - $6 Million
-2,642,834 Reduced 65.88%
1,368,630 $3.11 Million
Q4 2019

Feb 04, 2020

BUY
$0.63 - $2.27 $1.48 Million - $5.34 Million
2,352,025 Added 141.74%
4,011,464 $5.42 Million
Q3 2019

Nov 12, 2019

BUY
$0.59 - $0.9 $14,436 - $22,022
24,469 Added 1.5%
1,659,439 $1.05 Million
Q2 2019

Aug 15, 2019

SELL
$0.79 - $1.11 $61,564 - $86,502
-77,930 Reduced 4.55%
1,634,970 $1.4 Million
Q1 2019

May 03, 2019

BUY
$0.6 - $1.41 $1.03 Million - $2.42 Million
1,712,900 New
1,712,900 $1.87 Million

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.